ENTITY

Sage Therapeutics (SAGE US)

14
Analysis
Health CareUnited States
Sage Therapeutics, Inc. develops treatments for central nervous system disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. Sage Therapeutics operates in the United States.
more
bullishS&P 500 INDEX
05 Oct 2022 04:20

Another Bear Market Rally Brewing?; Stick With Biotech and Construction/Engineering Names

Early indications suggest another bear market rally in $SPX, and potentially that the lows are in, helped by short-term bearish engulfing patterns...

Logo
305 Views
Share
bullishS&P 500 INDEX
10 Aug 2022 06:18

S&P 500, Nasdaq 100 Testing Key Resistance Levels; Pause Likely; Buying Biotech

$SPX is testing important resistance in the 4165-4180 area, the same resistance level we were monitoring in early June before the market tumbled 13...

Logo
325 Views
Share
bullishS&P 500 INDEX
06 Mar 2019 06:17

S&P 500 and S&P 600 Testing Resistance...Still

The S&P 500 is beginning to come off of short-term overbought extremes, consolidating near the confluence of key overhead resistance and the...

Logo
200 Views
Share
bullishShionogi & Co
22 Jun 2018 18:30

Innovation to Help Maintain HIV Franchise Market Share and Weather Harsh Domestic Market Conditions

Continuous innovation at HIV Franchise to not only help defend market share…. Concerns about competition from Gilead Sciences Inc (GILD US)'s,...

05 Dec 2016 12:24

New Long Position: Gene Therapy for Parkinson's Disease and Upcoming Catalysts

Our next long position is Voyager Therapeutics Inc (VYGR US) , a Cambridge, Massachusetts-based emerging biotechnology company that is developing...

x